tyrosine and Hematologic Neoplasms

tyrosine has been researched along with Hematologic Neoplasms in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's1 (25.00)2.80

Authors

AuthorsStudies
Chavez, SA; Estrada Jimenez, VH; Kirken, RA; Li, L; Rodriguez Moncivais, OJ; Rodriguez, G; Sun, S1
Goyama, S; Huang, G; Kurokawa, M; Mulloy, JC1
Avila, R; Barroeta, A; Chirinos, P; Compagnone, RS; De Sanctis, JB; Martinez, GP; Mijares, MR; Ochoa, M; Suarez, AI1
Gilliland, DG; Ihle, JN1

Reviews

2 review(s) available for tyrosine and Hematologic Neoplasms

ArticleYear
Posttranslational modifications of RUNX1 as potential anticancer targets.
    Oncogene, 2015, Volume: 34, Issue:27

    Topics: Animals; Antineoplastic Agents; Base Sequence; Carcinogenesis; Core Binding Factor Alpha 2 Subunit; Hematologic Neoplasms; Humans; Lysine; Molecular Sequence Data; Molecular Targeted Therapy; Protein Processing, Post-Translational; Tyrosine

2015
Jak2: normal function and role in hematopoietic disorders.
    Current opinion in genetics & development, 2007, Volume: 17, Issue:1

    Topics: Gene Expression Regulation, Neoplastic; Hematologic Neoplasms; Humans; Janus Kinase 2; Models, Molecular; Mutation; Myeloproliferative Disorders; Phosphorylation; Protein Structure, Tertiary; Receptors, Cytokine; Signal Transduction; Translocation, Genetic; Tyrosine

2007

Other Studies

2 other study(ies) available for tyrosine and Hematologic Neoplasms

ArticleYear
Structural Analysis of Janus Tyrosine Kinase Variants in Hematological Malignancies: Implications for Drug Development and Opportunities for Novel Therapeutic Strategies.
    International journal of molecular sciences, 2023, Sep-26, Volume: 24, Issue:19

    Topics: Animals; Drug Development; Hematologic Neoplasms; Humans; Janus Kinase 1; Janus Kinase 2; Janus Kinases; Mice; Mutation; Receptors, Interferon; Tyrosine

2023
Cytotoxic effects of Fisturalin-3 and 11-Deoxyfisturalin-3 on Jurkat and U937 cell lines.
    Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia, 2013, Volume: 157, Issue:3

    Topics: Antibiotics, Antineoplastic; Apoptosis; Biological Products; Cell Cycle; Cell Proliferation; Cell Survival; Flow Cytometry; Hematologic Neoplasms; Humans; Inhibitory Concentration 50; Jurkat Cells; Tyrosine; U937 Cells

2013